Tech Earnings Season Starts Soon. Warnings Are Already Piling Up

With tech earnings season about to start, investors should be aware that a flurry of the industry’s less-followed players have been warning about emerging weakness across the enterprise and telecommunications-networking landscape.

Evercore ISI hardware analyst Amit Daryanani, speaking Tuesday on Barron’s Live, noted that heading into earnings he has concerns about weakness in IT enterprise spending, continued soft demand from communications carriers, and continued caution by consumers. The primary bright spot he sees heading into earnings: spending on cloud and AI infrastructure.

The list of companies providing cautious commentary on the outlook is growing by the day.

NetScout Systems stock (ticker: NTCT) is down 17% on Tuesday after the cybersecurity software company slashed its revenue forecast for its March 2024 fiscal year to a range of $840 million to $860 million, down from a previous forecast of $915 million to $945 million. NetScout also trimmed its adjusted profit per share forecast for the year to $2 to $2.20, down from $2.20 to $2.32. The company said it is seeing “slower order conversion,” due to “industry and economic headwinds facing our customers” that began in September.

Ericsson American depositary receipts (ERIC) are 3.3% lower after the networking infrastructure company on Tuesday provided disappointing financial guidance. “We expect the underlying uncertainty impacting our Mobile Networks business to persist into 2024,” the company said.

Adtran (ADTN), which provides networking hardware, on Monday warned that it now sees third-quarter revenue of $272.3 million, below its previous guidance range of $275 million to $305 million. Adtran said that its “customers remain focused on reducing inventory levels and managing capital expenses.”

Late last week, Belden (BDC), another network infrastructure provider, said it now sees third-quarter revenue of $625 million, down from a previous forecast of $675 million to $690 million. “Demand began to weaken in the third quarter, adding to ongoing pressure from channel destocking,” Belden said in its announcement. “We believe softer demand will continue as we move into the fourth quarter, impacting both revenue and profitability.”

A10 Networks (ATEN), which also provides networking infrastructure, likewise provided September quarter preliminary results that failed to match previous estimates. “In our third quarter we experienced delays related to North American service provider customers pushing out capital expenditures,” the company said earlier this month. “Deals we expected to close at the end of the quarter were delayed into future periods.”

Cambium Networks (CMBM), which provides wireless-network infrastructure, said earlier this month that it now sees third quarter revenue of $40 million to $45 million, below previous guidance of $62 million to $70 million. The company cited a number of reasons for the big miss, including a delay in government orders due to U.S. government budgetary timing issues, and a decrease in orders from distributors in the company’s enterprise business, among other things.

Tech earnings season kicks off Wednesday with results from Netflix (NFLX), to be followed by a deluge of financial reports next week from Alphabet (GOOGL), Microsoft (MSFT), International Business Machines (IBM), Meta Platforms (META), ServiceNow (NOW), Amazon.com (AMZN), Intel (INTC), and Juniper Networks (JNPR), among others.

There was a time — not so long ago — when the idea of an indulgent spa day was simply about relaxing massages and therapeutic facials, followed by a five-star lunch and perhaps a dip in a mineral pool. But the health and wellness industry has evolved rapidly, bringing with it an explosion of cutting-edge treatments designed to slow ageing, boost vitality, and extend healthspan.

Cold-water plunge pools, infrared saunas, and float tanks have taken over as the staples of health spas, wellness centres, and high-end gyms. Even real estate developments are tapping into this trend. But now, high-tech longevity treatments — from cryotherapy and IV infusions to genetic testing and advanced cellular therapies — are taking the wellness scene in Australia to unprecedented levels.

A burgeoning market globally, the health and wellness industry is estimated to have been worth more than US$5.6 trillion in 2022. Projections suggest this figure will grow to a staggering $13 trillion by 2031, with Australia steadily catching up to the US and Europe, where longevity treatments are thriving. High-profile figures like Gwyneth Paltrow, Jennifer Aniston, Chris Hemsworth, and even Tom Brady are among the faces championing biohacking and experimental therapies, from stem cell infusions to blood transfusions.

The Rise of Longevity Clinics in Australia
One of the key players in Australia’s emerging longevity scene is Tristan Sternson, founder of Super Young. Sternson’s foray into the world of longevity treatments began as he approached 40 — a milestone that made him reflect on his health. As a former elite athlete, the transition from feeling invincible to feeling vulnerable led him to explore solutions that would help him reclaim vitality.

Tristan Sternson, Nick Bell and Jarrod Kagan from Super Young

Initially frustrated by the lack of accessible health data locally, Sternson turned to overseas clinics for tests and treatments that painted a clearer picture of his biological needs. His experience inspired him to create Super Young, a Melbourne-based clinic offering evidence-based therapies tailored to individual needs. Services include cryotherapy, IV infusions, genetic testing, and biological age assessments. Memberships range from $85–$289 per week, while one-off tests start at $899.

Sternson emphasises the importance of personalised treatments. “I want people to start with the evidence side of it so they can really understand their own body and what treatments will work for them,” he says.

The Science of Longevity Medicine
Dr Karen Coates, an integrative medical doctor and a presenter for The Longevity Project at Gwinganna Lifestyle Retreat, echoes Sternson’s emphasis on personalisation. She explains that longevity isn’t just about living longer but about living better — optimising health today while securing vitality for the future.

“One-size-fits-all approaches don’t apply when it comes to longevity,” says Dr Coates. “It’s about understanding your body’s genetic makeup and adopting personalised strategies to support health and longevity.”

At Gwinganna’s four-night Longevity Project retreat, guests can undergo gene testing, biological age assessments, and learn strategies to bridge the gap between chronological and biological age. Packages for the retreat range from $2915 to $5460.

Biohacking for All Budgets
Not all longevity treatments come with hefty price tags. Health coach Camilla Thompson points out that simple lifestyle adjustments — like cold showers to stimulate circulation or adding Celtic sea salt to water for better hydration — can supplement advanced therapies.

While advanced treatments like stem cell and peptide therapies are yet to gain widespread regulatory approval in Australia, Sternson is optimistic about their future. He envisions a time when longevity centres will be as common as gyms, giving clients the tools to monitor and manage their health with precision.

“What I’d love to see is health insurance companies get on board,” Sternson adds. “If they can give discounts for safe driving based on car data, why not for healthy habits based on glucose monitoring or other health indicators?”

As Australia continues to embrace longevity medicine, it’s clear the industry is poised to reshape not just health and wellness but how Australians approach ageing itself.

Tech Earnings Season Starts Soon. Warnings Are Already Piling Up

As global demand for longevity treatments surges, Australia is fast becoming a player in this lucrative industry.